News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Paolo Tarantino: A lecture on novel treatments for HR+/HER2- MBC at IPO-Porto
Paolo Tarantino/LinkedIn
Feb 11, 2025, 10:28

Paolo Tarantino: A lecture on novel treatments for HR+/HER2- MBC at IPO-Porto

Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:

“Back to Porto for a lecture on novel treatments for HR+/HER2- metastatic breast cancer, 11 years after completing my med school year abroad in this city.

Still remains one of the most charming and inspiring places I know.

Thanks to the team at the Portuguese Institute of Oncology of Porto (IPO-Porto) for having me!”

Paolo Tarantino: A lecture on novel treatments for HR+/HER2- MBC at IPO-Porto

More posts featuring Paolo Tarantino.

cancer IPO-Porto metastatic breast cancer OncoDaily Oncology Paolo Tarantino Portuguese Institute of Oncology of Porto
Special Coverage
Blog
Feb 11, 2025, 10:28
Recognizing the power of women in oncology - City Cancer Challenge
Blog
Feb 11, 2025, 10:28
Paolo Tarantino: A lecture on novel treatments for HR+/HER2- MBC at IPO-Porto
Blog
Feb 11, 2025, 10:24
Estelamari Rodriguez: Dolphins Cancer Challenge is in 2 weeks
Blog
Feb 11, 2025, 10:21
Charles Jiang: A visualization tool for adjuvant therapy risks and benefits discussion
Career
Feb 11, 2025, 10:19
Philippe Bedard Received 2025 TAT Honorary Award for Contributions to Cancer Research
Science
Feb 11, 2025, 10:15
David Palma: Growing evidence for using sim-free RT for palliative cases
Insight
Feb 11, 2025, 10:06
Health behaviors in adult male cancer survivors and the general male population in Korea - MASCC
Science
Feb 11, 2025, 10:06
Al-Ola Abdallah: Plasma cell infiltration rates with 18F-FDG PET/CT in multiple myeloma
Insight
Feb 11, 2025, 09:58
The Scottish Medicines Consortium has recommended olaparib to treat NHS patients with advanced breast cancer - ICR
Insight
Feb 11, 2025, 09:58
Thor Halfdanarson: Functional imaging in neuroendocrine neoplasms
Blog
Feb 11, 2025, 09:53
William Breitbart: 2025 Psychopharmacology virtual course for clinicians of all disciplines
Career
Feb 11, 2025, 09:48
Don Dizon: Excellence in Equity Award, endowed by the American Cancer Society